Status:
COMPLETED
School-based Asthma Therapy: Stage 2 Effectiveness Study
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Halcyon Hill Foundation
Conditions:
Asthma
Eligibility:
All Genders
3-10 years
Phase:
NA
Brief Summary
Asthma is the most common chronic illness of childhood, and hospitalization rates are increasing. In the US, impoverished children and children from minority ethnic and racial backgrounds suffer dispr...
Eligibility Criteria
Inclusion
- Physician-diagnosed asthma
- Mild persistent to severe persistent asthma
- Ages 3-10 years
- Attending school in the Rochester City School District preschools or elementary schools
- Signed physician permission to enroll the child
- Parent or caregiver must consent to the intervention
Exclusion
- Inability to speak and understand either English or Spanish
- No access to a working phone for follow-up surveys
- The family planning to leave the school district within fewer than 6 months
- The child having other significant medical conditions that could interfere with the assessment of asthma-related outcome measures
- children in foster care or other situations in which consent cannot be obtained from a guardian
- Current participation in other local asthma interventions
Key Trial Info
Start Date :
August 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
530 Patients enrolled
Trial Details
Trial ID
NCT01175369
Start Date
August 1 2006
End Date
January 1 2012
Last Update
August 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14642